Skip to main content

Table 2 Echocardiographic measurements in all patients and according to heart failure stages

From: Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation – Results from the German EuroAspire IV cohort

  

Heart Failure Stage

 
 

Total

A

B

C

p

N (%)

509

20 (3.9)

264 (51.9)

225 (44.2)

 

LVEF (%), median (IQR)

58 (53–62)

64 (58–67)

59 (55–63)

56 (50–61)

<0.0011

LVEF categories, n (%)

  < 30%

7 (1.4)

0

2 (0.8)

5 (2.3)

0.0412

 30–39%

23 (4.5)

0

10 (3.8)

13 (6.1)

 40–52%

80 (15.6)

1 (5.0)

32 (12.1)

43 (20.1)

  > 52%

402 (78.5)

19 (95.0)

220 (83.3)

153 (71.5)

 

Wall motion abnormalities, n (%)

138 (28.1)

2 (10.0)

59 (23.4)

74 (35.7)

0.0032

LVEDVI (ml/m2), median (IQR)

60 (50–72)

49 (40–56)

60 (50–69)

61 (53–79)

<0.0011

LV mass index (g/m2), median (IQR)

93 (78–110)

82 (64–95)

92 (77–108)

99 (82–120)

<0.0011

LAA (cm2), median (IQR)

20 (17–23)

18 (16–20)

20 (17–23)

20 (17–24)

0.0381

E/e´, median (IQR)

9 (7.2–11.4)

6.8 (5.5–8.4)

8.8 (7.2–10.8)

9.5 (7.5–12.1)

<0.0011

  1. LV left ventricle, EF ejection fraction, IQR interquartile range, LVEDVI LV end-diastolic volume index, LAA left atrial area, E/e´ LV filling index (transmitral inflow velocity to annular velocity ratio)
  2. 1Kruskal-Wallis test
  3. 2Fisher’s exact test